These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 34095857)

  • 1. Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study.
    Hsu TY; D'Silva KM; Patel NJ; Wang J; Mueller AA; Fu X; Prisco L; Martin L; Vanni KMM; Zaccardelli A; Cook C; Choi HK; Zhang Y; Gravallese EM; Wallace ZS; Sparks JA
    Lancet Rheumatol; 2021 Sep; 3(9):e638-e647. PubMed ID: 34095857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study.
    Webb BJ; Peltan ID; Jensen P; Hoda D; Hunter B; Silver A; Starr N; Buckel W; Grisel N; Hummel E; Snow G; Morris D; Stenehjem E; Srivastava R; Brown SM
    Lancet Rheumatol; 2020 Dec; 2(12):e754-e763. PubMed ID: 33015645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Admission COVID-19 Associated Hyperinflammation Syndrome Score in Critically-Ill COVID-19 Patients.
    Yildirim M; Halacli B; Yuce D; Gunegul Y; Ersoy EO; Topeli A
    J Intensive Care Med; 2023 Jan; 38(1):70-77. PubMed ID: 36213939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic.
    Serling-Boyd N; D'Silva KM; Hsu TY; Wallwork R; Fu X; Gravallese EM; Jorge AM; Zhang Y; Choi H; Sparks JA; Wallace ZS
    Ann Rheum Dis; 2021 May; 80(5):660-666. PubMed ID: 33257496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study.
    D'Silva KM; Jorge A; Cohen A; McCormick N; Zhang Y; Wallace ZS; Choi HK
    Arthritis Rheumatol; 2021 Jun; 73(6):914-920. PubMed ID: 33305544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study.
    Cavalli G; Larcher A; Tomelleri A; Campochiaro C; Della-Torre E; De Luca G; Farina N; Boffini N; Ruggeri A; Poli A; Scarpellini P; Rovere-Querini P; Tresoldi M; Salonia A; Montorsi F; Landoni G; Castagna A; Ciceri F; Zangrillo A; Dagna L
    Lancet Rheumatol; 2021 Apr; 3(4):e253-e261. PubMed ID: 33655218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'.
    D'Silva KM; Serling-Boyd N; Wallwork R; Hsu T; Fu X; Gravallese EM; Choi HK; Sparks JA; Wallace ZS
    Ann Rheum Dis; 2020 Sep; 79(9):1156-1162. PubMed ID: 32457048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study.
    Qian G; Wang X; Patel NJ; Kawano Y; Fu X; Cook CE; Vanni KMM; Kowalski EN; Banasiak EP; Bade KJ; Srivatsan S; Williams ZK; Todd DJ; Weinblatt ME; Wallace ZS; Sparks JA
    Lancet Rheumatol; 2023 Mar; 5(3):e139-e150. PubMed ID: 36844970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study.
    Jorge A; D'Silva KM; Cohen A; Wallace ZS; McCormick N; Zhang Y; Choi HK
    Lancet Rheumatol; 2021 Feb; 3(2):e131-e137. PubMed ID: 33392516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2.
    De Rop L; Bos DA; Stegeman I; Holtman G; Ochodo EA; Spijker R; Otieno JA; Alkhlaileh F; Deeks JJ; Dinnes J; Van den Bruel A; McInnes MD; Leeflang MM; ; Verbakel JY
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD015050. PubMed ID: 39105481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study.
    De Luca G; Cavalli G; Campochiaro C; Della-Torre E; Angelillo P; Tomelleri A; Boffini N; Tentori S; Mette F; Farina N; Rovere-Querini P; Ruggeri A; D'Aliberti T; Scarpellini P; Landoni G; De Cobelli F; Paolini JF; Zangrillo A; Tresoldi M; Trapnell BC; Ciceri F; Dagna L
    Lancet Rheumatol; 2020 Aug; 2(8):e465-e473. PubMed ID: 32835256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.
    Shin YH; Shin JI; Moon SY; Jin HY; Kim SY; Yang JM; Cho SH; Kim S; Lee M; Park Y; Kim MS; Won HH; Hong SH; Kronbichler A; Koyanagi A; Jacob L; Smith L; Lee KH; Suh DI; Lee SW; Yon DK
    Lancet Rheumatol; 2021 Oct; 3(10):e698-e706. PubMed ID: 34179832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the Severity of COVID-19 Lung Injury in Rheumatic Diseases Versus the General Population Using Deep Learning-Derived Chest Radiograph Scores.
    Patel NJ; D'Silva KM; Li MD; Hsu TYT; DiIorio M; Fu X; Cook C; Prisco L; Martin L; Vanni KMM; Zaccardelli A; Zhang Y; Kalpathy-Cramer J; Sparks JA; Wallace ZS
    Arthritis Care Res (Hoboken); 2023 Mar; 75(3):657-666. PubMed ID: 35313091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study.
    Manson JJ; Crooks C; Naja M; Ledlie A; Goulden B; Liddle T; Khan E; Mehta P; Martin-Gutierrez L; Waddington KE; Robinson GA; Ribeiro Santos L; McLoughlin E; Snell A; Adeney C; Schim van der Loeff I; Baker KF; Duncan CJA; Hanrath AT; Lendrem BC; De Soyza A; Peng J; J'Bari H; Greenwood M; Hawkins E; Peckham H; Marks M; Rampling T; Luintel A; Williams B; Brown M; Singer M; West J; Jury EC; Collin M; Tattersall RS
    Lancet Rheumatol; 2020 Oct; 2(10):e594-e602. PubMed ID: 32864628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality Prediction of COVID-19 Patients at Intensive Care Unit Admission.
    Ganesan R; Mahajan V; Singla K; Konar S; Samra T; Sundaram SK; Suri V; Garg M; Kalra N; Puri GD
    Cureus; 2021 Nov; 13(11):e19690. PubMed ID: 34976472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.
    Murthy S; Archambault PM; Atique A; Carrier FM; Cheng MP; Codan C; Daneman N; Dechert W; Douglas S; Fiest KM; Fowler R; Goco G; Gu Y; Guerguerian AM; Hall R; Hsu JM; Joffe A; Jouvet P; Kelly L; Kho ME; Kruisselbrink RJ; Kumar D; Kutsogiannis DJ; Lamontagne F; Lee TC; Menon K; O'Grady H; O'Hearn K; Ovakim DH; Pharand SG; Pitre T; Reel R; Reeve B; Rewa O; Richardson D; Rishu A; Sandhu G; Sarfo-Mensah S; Shadowitz E; Sligl W; Solomon J; Stelfox HT; Swanson A; Tessier-Grenier H; Tsang JLY; Wood G;
    CMAJ Open; 2021; 9(1):E181-E188. PubMed ID: 33688026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study.
    Estenssoro E; Loudet CI; Ríos FG; Kanoore Edul VS; Plotnikow G; Andrian M; Romero I; Piezny D; Bezzi M; Mandich V; Groer C; Torres S; Orlandi C; Rubatto Birri PN; Valenti MF; Cunto E; Sáenz MG; Tiribelli N; Aphalo V; Reina R; Dubin A;
    Lancet Respir Med; 2021 Sep; 9(9):989-998. PubMed ID: 34224674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.